Literature DB >> 30927211

Illuminating Elimination Diets: Controversies Regarding Dietary Treatment of Eosinophilic Esophagitis.

Cary C Cotton1, Raquel Durban2,3, Evan S Dellon4.   

Abstract

Eosinophilic esophagitis (EoE) is an immune-mediated disease triggered by food antigens for which dietary elimination treatment can induce and sustain histologic remission. Our review aims to describe the state of the art regarding dietary treatment of EoE, highlighting a number of areas of controversy related to dietary therapy in EoE, including novel modalities for determining food triggers, making the empiric dietary elimination process more efficient, issues of cross-contamination and "dosing" of how much food to avoid or add back, costs and effects on quality of life, long-term efficacy, and the risk of developing immediate IgE-type reactions after initial dietary elimination. Elemental formulas, empiric elimination diets, and targeted allergy test-directed elimination diets are well-described treatments for EoE. Although elemental diets are most efficacious, their clinical use is limited by cost and the palatability of an exclusively liquid diet. While empiric elimination is less effective than elemental formula-based diets, they are more easily implemented and often sustainable. Since the comparative effectiveness of elimination diets with proton-pump inhibitors and swallowed topical steroids remains unknown, there are multiple areas to address with future research.

Entities:  

Keywords:  Allergy; Diet; Eosinophilic esophagitis; Food elimination; Treatment

Mesh:

Substances:

Year:  2019        PMID: 30927211      PMCID: PMC6532639          DOI: 10.1007/s10620-019-05602-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  76 in total

1.  Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.

Authors:  P G Kruszewski; J M Russo; J P Franciosi; J W Varni; T A E Platts-Mills; E A Erwin
Journal:  Dis Esophagus       Date:  2015-02-26       Impact factor: 3.429

2.  Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.

Authors:  Bram D van Rhijn; Pim W Weijenborg; Joanne Verheij; Marius A van den Bergh Weerman; Caroline Verseijden; René M J G J van den Wijngaard; Wouter J de Jonge; Andreas J P M Smout; Albert J Bredenoord
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-19       Impact factor: 11.382

3.  Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis.

Authors:  Á Arias; A J Lucendo; P Martínez-Fernández; A M González-Castro; M Fortea; J González-Cervera; J L Yagüe-Compadre; T Mota-Huertas; M Vicario
Journal:  Clin Exp Allergy       Date:  2016-01       Impact factor: 5.018

4.  Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities.

Authors:  H Philpott; S Nandurkar; S G Royce; F Thien; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2016-06-01       Impact factor: 8.171

5.  Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States.

Authors:  Elizabeth T Jensen; Michael D Kappelman; Christopher F Martin; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2014-09-30       Impact factor: 10.864

6.  Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.

Authors:  Nirmala Gonsalves; Guang-Yu Yang; Bethany Doerfler; Sally Ritz; Anne M Ditto; Ikuo Hirano
Journal:  Gastroenterology       Date:  2012-03-03       Impact factor: 22.682

7.  An etiological role for aeroallergens and eosinophils in experimental esophagitis.

Authors:  A Mishra; S P Hogan; E B Brandt; M E Rothenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

8.  Value of microarray allergen assay in the management of eosinophilic oesophagitis.

Authors:  A Armentia; S Martín; J Barrio; B Martín; J C García; J M Vega; A Sánchez; P Fernández; A Corell
Journal:  Allergol Immunopathol (Madr)       Date:  2014-06-22       Impact factor: 1.667

9.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.

Authors:  Edaire Cheng; Xi Zhang; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; David H Wang; Stuart Jon Spechler; Rhonda F Souza
Journal:  Gut       Date:  2012-05-12       Impact factor: 23.059

Review 10.  The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?

Authors:  Hamish Philpott; Evan S Dellon
Journal:  J Gastroenterol       Date:  2017-10-10       Impact factor: 7.527

View more
  4 in total

Review 1.  Emerging therapies for eosinophilic esophagitis.

Authors:  Thomas Greuter; Ikuo Hirano; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2019-11-06       Impact factor: 10.793

2.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

Review 3.  Red Between the Lines: Evolution of Eosinophilic Esophagitis as a Distinct Clinicopathologic Syndrome.

Authors:  Evan S Dellon
Journal:  Dig Dis Sci       Date:  2020-10-14       Impact factor: 3.199

4.  Health Service Use and Treatment Choices for Pediatric Eosinophilic Esophagitis: Findings From a Cross-Sectional Survey of Australian Carers.

Authors:  Nicole Hannan; Amie Steel; Sara S McMillan; Evelin Tiralongo
Journal:  Front Pediatr       Date:  2020-04-17       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.